These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10772630)

  • 1. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein.
    Wang EJ; Casciano CN; Clement RP; Johnson WW
    Drug Metab Dispos; 2000 May; 28(5):522-8. PubMed ID: 10772630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK; Zhu GY; Shen XL; Chattopadhyay A; Dey S; Fong WF
    Biochem Pharmacol; 2006 Sep; 72(7):824-37. PubMed ID: 16889754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of beta-adrenergic antagonists, H1-receptor blockers, analgesics, diuretics, and quinolone antibiotics on the cellular accumulation of the anticancer drug, daunorubicin: P-glycoprotein modulation.
    Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
    Anticancer Res; 2001; 21(2A):847-56. PubMed ID: 11396174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.
    Barattin R; Gerby B; Bourges K; Hardy G; Olivares J; Boutonnat J; Arnoult C; D'Hardemare AD; Ronot X
    Anticancer Res; 2010 Jul; 30(7):2553-9. PubMed ID: 20682982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH; Kang G; Min YD
    Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
    Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
    Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.
    Meschini S; Marra M; Condello M; Calcabrini A; Federici E; Dupuis ML; Cianfriglia M; Arancia G
    Int J Oncol; 2005 Dec; 27(6):1597-603. PubMed ID: 16273216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flow cell assay for evaluation of whole cell drug efflux kinetics: analysis of paclitaxel efflux in CCRF-CEM leukemia cells overexpressing P-glycoprotein.
    Lin JT; Sharma R; Grady JJ; Awasthi S
    Drug Metab Dispos; 2001 Feb; 29(2):103-10. PubMed ID: 11159798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.
    Hayeshi R; Masimirembwa C; Mukanganyama S; Ungell AL
    Eur J Pharm Sci; 2006 Sep; 29(1):70-81. PubMed ID: 16846720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation.
    Ibrahim S; Peggins J; Knapton A; Licht T; Aszalos A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1276-83. PubMed ID: 11082465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
    Fong WF; Wan CK; Zhu GY; Chattopadhyay A; Dey S; Zhao Z; Shen XL
    Planta Med; 2007 Mar; 73(3):212-20. PubMed ID: 17318783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum.
    Lehnert M; de Giuli R; Twentyman PR
    Clin Cancer Res; 1996 Feb; 2(2):403-10. PubMed ID: 9816184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.